Company Filing History:
Years Active: 2016
Title: Innovator Chi-ting Chang: Advancing Drug Prediction with Microfluidic Technology
Introduction
Chi-ting Chang is a notable inventor based in Seattle, Washington, recognized for his innovative contributions in the field of microfluidics. With a single patent to his name, he has made significant strides in developing methods and apparatuses aimed at drug prediction, showcasing his expertise in both engineering and biological applications.
Latest Patents
Chi-ting Chang's patent, titled "Microfluidic Assay Apparatus and Methods of Use," centers on revolutionary techniques in drug prediction. The microfluidic apparatus includes a plate with multiple defined wells and closed microchannels that communicate with open microchannels on a sample platform. This innovative design allows for enhanced efficiency and accuracy in drug testing, highlighting the potential of microfluidic technology in biomedical research.
Career Highlights
Chi-ting Chang is associated with the University of Washington, where he continues to explore advancements in microfluidics. His work focuses on the intersection of engineering and biology, aiming to improve methodologies in drug discovery. The impact of his research is significant within both academic and clinical settings, contributing to the ongoing evolution of laboratory techniques.
Collaborations
Chang has collaborated with esteemed colleagues, including Albert Folch and Raymond J Monnat. These partnerships not only enhance the research environment at the University of Washington but also foster innovative solutions in the realm of microfluidic technology and its applications in medicine.
Conclusion
Chi-ting Chang exemplifies the spirit of innovation through his development of a microfluidic assay apparatus. His contributions not only advance drug prediction methodologies but also highlight the importance of collaboration in research. As he continues to work at the University of Washington, his inventions promise to play a critical role in the future of biomedical engineering.